Clinical Trial Update: Intra-Individual Reproducibility of the Non-Invasive Assessment of the Portal Circulation [NA]

View source ↗

Summary

Completed clinical trial assessing intra-individual reproducibility of non-invasive portal circulation assessment using HepQuant technology; results posted in 2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C
• Non-alcoholic Fatty Liver Disease

Snippet

Sponsor: HepQuant, LLC | Conditions: Hepatitis C, Chronic, Non-Alcoholic Fatty Liver Disease | NA | Status: COMPLETED | Results posted: 2021-07-15